STUDI PENGGUNAAN ANTIHIPERTENSI GOLONGAN CALCIUM CHANNEL BLOCKER PADA PASIEN STROKE HEMORAGIK (Penelitian Dilakukan di Rumah Sakit Umum Daerah Sidoarjo)
Daftar Isi:
- Background : Stroke is a disease that occurs due to decreased neurological function that appears in at least 24 hours. In stroke patients the main cause is hypertension. Hypertension occurs when blood pressure ≥ 140/90 mmHg. In controlling the causes of stroke, antihypertensive administration is very important. All classes of antihypertensive can be accepted by stroke patients, as long as it can reduce blood pressure effectively. Antihypertensive groups include ACE-I, Diuretics, β-Blockers, ARB, and CCB. Antihypertensive which has a greater effectiveness for stroke prevention is Calcium Channel Blocker. Antihypertensive administration in hemorrhagic stroke patients when systolic blood pressure is more than 180 mmHg. The average reduction must not exceed 10-20% of the MAP. Objective :To determine the pattern of antihypertensive use of the CCB (Calcium channel blocker) in hemorrhagic stroke patients. Includes types of preparation, doses, routes, and duration of therapy. Method :Retrospective observational in hemorrhagic stroke patients at general hospital of Sidoarjo from January-June 2019. Result and Conclusion: Antihypertensive CCB was used single as many as 18 patients (49%) and a combination of 19 patients (51%), the single most widely used was Amlodipin (1 x 10mg) PO as many as 22 patients (50%), and the use of the most used combination is Amlodipin (1 x 10 mg) PO + Candesartan (1 x 8mg) PO in 9 patients (48%). The most widely used pattern of antihypertensive switching CCB is Nicardipine (0.5μg / kgBW / min) IV → Amlodipine (1 x 10 mg) PO in 11 patients (75%). Nicardipine was only used as an emergency antihypertensive in 12 patients (29%).